Testing was to be performed on five separate days on fresh plasma samples from four normal subjects and 12 patients stabilised for at least six weeks with oral anticoagulants. INR were to be between 1 5 and 4 5. The exercise was to be completed within four hours of blood being collected. A single exercise was designed as follows: the specimens were collected, by clean venepuncture, into a 1 in 10 volume of sterile trisodium citrate 0I109 to 0 120 mol/l, into a plastic or polypropylene syringe, and transferred into a non-wettable container. If an evacuated tube was used the brand selected had to be sufficiently siliconised. First 1-2 hours: collection and preparation of test samples. The blood was centrifuged immediately after withdrawal and the plasma transferred to a non-wettable, stoppered container. Specimens were maintained at room temperature until required for testing. Second 2 hours: testing of the 16 fresh plasma samples with the three thromboplastins was done according to a randomised sequence provided.
The international system for prothrombin time standardisation is based on the calibration of local and commercial thromboplastins in terms of the WHO first primary International Reference Preparation (IRP). ' Testing was to be performed on five separate days on fresh plasma samples from four normal subjects and 12 patients stabilised for at least six weeks with oral anticoagulants. INR were to be between 1 5 and 4 5. The exercise was to be completed within four hours of blood being collected. A single exercise was designed as follows: the specimens were collected, by clean venepuncture, into a 1 in 10 volume of sterile trisodium citrate 0I109 to 0 120 mol/l, into a plastic or polypropylene syringe, and transferred into a non-wettable container. If an evacuated tube was used the brand selected had to be sufficiently siliconised. First 1-2 hours: collection and preparation of test samples. The blood was centrifuged immediately after withdrawal and the plasma transferred to a non-wettable, stoppered container. Specimens were maintained at room temperature until required for testing. Second 2 hours: testing of the 16 fresh plasma samples with the three thromboplastins was done according to a randomised sequence provided.
Single determinations were requested and the three prothrombin times on each plasma (one with each thromboplastin) were performed immediately after each other.
The order in which the patients were to be tested was the same as the order of collection.
The first normal control sample was collected before the treated patients' samples and the fourth normal control collected last, after the patients' samples.
The coagulation end-point was to be based on a manual (tilt tube) technique with a recommended procedure for the Quick test.
A one factor analysis of variance was carried out on the INR biases (rabbit plain-human plain) to investigate differences among the four centres. The size of the bias was assessed for each centre using t tests on the parameters derived from the analysis of variance model.
Results
Eighty normal subjects and 241 treated patients were tested at the four centres. The results are given in the table below.
The study reveals a highly significant difference between the INR results from the use of the two main WHO IRP for thromboplastin, rabbit plain and human plain (figure). There has been difficulty in their interpretation because of the small numbers of samples in the external quality assessment exercises, the variability of the effect with different test samples due to varying responsiveness of individual reagents to depression of different clotting factors, and the uncertainty of the effects of lyophilisation on the test samples. As the differences in the present study were found in fresh plasmas they indicate that the discrepancies cannot be ascribed simply to artefactual changes from lyophilisation in the plasma samples, but can be regarded with confidence as genuine INR differences. The order of differences (mean 7 35%) is, however, not great in terms of clinical dose of warfarin and of relatively insignificant importance compared with the several fold variation in warfarin dose at different centres before the introduction of the INR system.7
The question therefore arises concerning the best route of calibration for a new rabbit plain IRP and for routine commercial rabbit preparations. There are a number of arguments in favour of INR derived from the human IRP calibration route. First, the human plain primary IRP used in this study, as well as being specially designated by WHO, has provided much of the basis for recommendations on therapeutic ranges. This is derived from the cumulative experience in clinical practice and prospective randomised clinical trials with dose control based on human brain thromboplastins calibrated in terms of the human plain IRP. [8] [9] [10] There are also clinical data on therapeutic ranges to support recommendations in terms of the bovine combined preparation (OBT/79) INR which are similar to the human plain. These are derived from the experience largely in the Scandinavian countries and the Netherlands. The implications of the data were incorporated in the above recommendations on therapeutic ranges. The bovine combined type of prothrombin time is, however, a relatively uncommon procedure worldwide and this was one of the reasons put forward for the choice of the second human plain primary IRP as replacement for the first WHO primary IRP which was a combined reagent." the observation that the precision of the INR is partly dependent on the International Sensitivity Index (ISI), the lower the ISI the greater the precision."2 The rabbit IRP has a considerably higher ISI (1.41) compared with 1 085 for the human plain IRP. Furthermore, the original calibration of the rabbit plain IRP gave a considerably higher SD than did the parallel calibrations of the human plain and the bovine combined,2 and was also much higher than the WHO human plain calibration.3 This imprecision in ISI calibration is necessarily carried forward with every subsequent ISI calibration based on the rabbit plain IRP.
Finally, the decision to adopt the ISI based on the human plain preparation would accord with the recommendation of the WHO Biological Standards Committee that future IRP should be calibrated against the human plain IRP BCT/253.4
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